Study
Melatonin May Reduce Migraine Frequency in Adults
Research suggests melatonin supplementation could help decrease the frequency and severity of migraines in adults.
Pain ManagementSleepBrain Health
Summary
In plain language
Recent research highlights that taking melatonin, a natural hormone that regulates sleep, might help reduce migraine frequency and severity in adults. The study reviewed various trials where melatonin was compared to other treatments and a placebo. Findings indicate that melatonin can be an effective and safe option for preventing migraines. This is particularly relevant for seniors who experience migraines and are looking for new prevention methods. However, it’s always wise to consult with a healthcare provider before starting any new supplement.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
The study combined results from nine different trials to understand melatonin's effect on migraines.
- Researchers found that melatonin, particularly in doses ranging from 2 mg to 6 mg, could reduce the frequency and intensity of migraine attacks.
- While the study showed promising results, it noted that the number of participants and studies was limited, suggesting a need for more research.
- For seniors, adding melatonin could be an easy, natural way to manage migraines, but it’s important to discuss any new supplement with a healthcare provider to ensure it’s right for you.
Remember, always consult with your doctor before starting new treatments.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Peer-reviewed publication · Meta-Analysis
Melatonin May Reduce Migraine Frequency in Adults
Published January 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
This meta-analysis is of high methodological quality, adhering to PRISMA guidelines and using robust statistical methods. It provides a comprehensive evaluation of melatonin's efficacy in migraine prophylaxis, though its relevance to seniors is limited due to the inclusion of mixed age groups.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 10.0/10 | |
| Bias & Methods | 10.0/10 | |
| Statistical Integrity | 10.0/10 | |
| Transparency | 10.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 10.0/10 | |
| Relevance to Seniors | 5.0/10 | |
| Journal Quality | 10.0/10 |
Additional Notes
The study's focus on melatonin for migraine prophylaxis is relevant to a broad audience, but specific insights for seniors are limited. Future research could benefit from subgroup analyses focusing on older adults.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.